Coronavirus Open Thread (October-December 2020)

I’m not from the US I don’t care what they do there.

Last time I looked you barely had mandatory health insurance.

Apparently, though, governments DO have the constitutional power to tell people who they may associate with, where they can go, when they can go there, what they must wear, and under what circumstances their bodies are the property of the State.

In any case, nobody’s suggesting telling people what they’re allowed to eat and not eat. Merely that they should be told some relevant facts.

This is bizarre shit, Brian. I really don’t think you’ve examined your ideological position for internal consistency.

1 Like

For many underserved areas in the US, it is actually easier to get crap food than good food. These food deserts, typically in low income areas, have high numbers of fast food places and convenience stores and low numbers of grocery stores. Not completely off topic if it contributes to disparities observed in Covid-related illness.

Apart from the no eating dogs, people, certain porn , incest etc democratic secular governments do NOT get involved in people’s lifestyle choices.

That’s why they are secular democratic societies.

You aren’t telling me anything I or most of us don’t known already.
My point is that requires long term change.

If we look at the title of the thread it’s ‘Coronavirus Oct/Nov’.

1 Like

Agreed, but seems to be the most viable for now if t/e vaccines have good safety profiles. We are not going to solve metabolic issues and aging overnight.

1 Like

You’re not from the US so you probably shouldn’t talk about health insurance in the US unless you’ve studied it.

The ACA’s community rating provision prohibits the use of health status underwriting. If you read up on this, and look at the cost of the plans Americans are effectively forced to buy, you’ll understand why poor diet and lifestyle choices are an issue for everybody.

Actually I have.

But DONT keep on harping on about the US.

So boringgggg.

This is TAIWAN.

1 Like

And this is a coronavirus open thread. If you don’t like people talking about coronavirus-related issues you find boringgggg, you can “just move to Saudi Arabia” and start your own fundamentalist forum. :wink:

Going on and on and on and on about the US.:sleeping::sleeping::sleeping::sleeping::sleeping:
This is a global coronavirus thread on a forum based in Taiwan.

It’s not the US politics thread.

1 Like

Yes.

What constitutes a "good safety profile "though? We’re talking about rapidly vaccinating tens if not hundreds of millions of people with a new type of vaccine (mRNA) that has never before been approved for use in human populations.

There’s risk involved. How high or low? We don’t really know without longitudinal data. What we do know is that if you’re under the age of 70 and don’t have a metabolic disorder, your risk of dying from the coronavirus is exceedingly low.

It is a fair point, and I usually favor older drugs to newer ones, all things being equal. But not all of the phase 3 candidates are mRNA based.

https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker

I am pretty risk averse when it comes to drugs, but I think I will be an early adopter (if possible) because of the public health aspects.

Then you can wait for the vaccines that are based on more proven technology and also cheaper .e.g the Oxford one. But the trials so far said they aren’t as effective potentially.

Or you could just not get vaccinated at all. But you won’t be able to travel anywhere of note eventually.

Moderna Chief Medical Officer Tal Zaks told Axios that the public should not “over-interpret” the vaccine trial results to assume life could go back to normal after adults are vaccinated.

Zaks warned that the trial results show that the vaccine can prevent someone from getting sick or “severely sick,” from COVID-19, however, the results don’t show that the vaccine prevents transmission of the virus.

“They do not show that they prevent you from potentially carrying this virus transiently and infecting others,” Zaks said in an interview for “Axios,” the outlet’s show on HBO.

Zaks added: “When we start the deployment of this vaccine we will not have sufficient concrete data to prove that this vaccine reduces transmission.”

While he believes based on the science that it’s likely that vaccine does prevent transmission, there’s still no solid proof of that.

“I think it’s important that we don’t change behavior solely on the basis of vaccination,” he said.

So we’re all going to get vaccinated so that life can return to normal, but one of the vaccine makers is saying that life shouldn’t go back to to normal just because we’ve been vaccinated. Got it. :roll_eyes:

1 Like

There simply isn’t enough data to make a claim regarding transmission. That will probably require real word follow up data after the vaccines are approved.

1 Like

He cannot overstate the claims or FDA will block it.

And that’s precisely the problem.

The public is being told that a vaccine will allow life to return to normal if large enough percentages of people are vaccinated, but in actuality, that’s not quite the case.

We don’t know if the vaccines prevent infection or mute symptoms. We don’t know if they prevent transmission. We don’t know how long any immunity will last. We don’t know how effective they are in the most vulnerable groups. And there’s no longitudinal data supporting the efficacy and safety of mRNA vaccines.

When it boils down to it, it’s basically “you need to take the vaccine to find out what exactly it does.” Not exactly a convincing sales pitch to people who are already skeptical about the vaccines and the process by which they’re coming to market.

Of course, there are risks with all new vaccines, but this time, we’re talking about running a huge experiment on millions of people.

1 Like

All vaccines have to pass three rigoroous clinical trials,the third of which often involves 30,000 people and up,their safety will be relatively well characterized.

1 Like

Not a fair assessment. Endpoints for prevention trials should include reductions in lab-conformed infection and maybe symptoms. Along with safety measures of course.

https://www.fda.gov/media/137926/download

1 Like